dalteparin has been researched along with phenprocoumon in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 13 (52.00) | 29.6817 |
| 2010's | 10 (40.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breuer, HW; Greinacher, A; Müller, R | 1 |
| Blättler, IK; Blättler, W; Kreis, N | 1 |
| Fetsch, T; Grewe, R; Hanrath, P; Hofmann, T; Kühle, K; Lehmacher, W; Nixdorff, U; Schmidt-Lucke, JA; Stellbrink, C | 1 |
| Beer, JH; Bernard-Bagattini, S; Bounameaux, H; Burger, M; Gretener, S | 1 |
| Bechtold, H; Fung, S; Gunzenhauser, D; Janssen, D; Sawitzki, H | 1 |
| Daniel, WG; Geller, C; Hanrath, P; Hofmann, T; Lehmacher, W; Mügge, A; Nixdorff, U; Schmidt-Lucke, C; Schmidt-Lucke, JA; Sehnert, W; Stellbrink, C | 2 |
| Benesch, T; Dimopoulos-Xicki, L; Haas, M; Kodras, K; Neumann, I; Ziai, F | 1 |
| Verheugt, FW | 1 |
| Daniel, WG; Grewe, R; Hanrath, P; Hofmann, T; Klein, HU; Meurer, J; Mügge, A; Nixdorff, U; Paar, WD; Schmidt-Lucke, C; Schmidt-Lucke, JA; Stellbrink, C | 1 |
| Brecht, JG; Huppertz, E; Lehmacher, W; Nixdorff, U; Schädlich, PK; Schmidt-Lucke, C; Stellbrink, C | 1 |
| Hammerstingl, C; Omran, H; Poetzsch, B; Tripp, C | 1 |
| Bremerich, J; Christ, M; Wandeler-Meyer, K | 1 |
| Dickhuth, HH; König, D; Korsten-Reck, U; Winterer, J | 1 |
| Essers, E; Gottstein, S; Klamroth, R; Landgraf, H | 1 |
| Broemel, T; Kasch, F; Leithäuser, B; Park, JW | 1 |
| Dähnert, I; Dhein, S; Klein, M; Klein, N; Pfeiffer, D; Salameh, A | 1 |
| Basnyat, B; Küpper, T; Shrestha, P; van der Giet, S | 1 |
| Finsterer, J; Reiter, M; Schäffl-Doweik, L; Stöllberger, C | 1 |
| Gabriëls, L; Labarque, V; Renard, M; Roie, EV; Van Geet, C | 1 |
| Klein, HH | 1 |
| Bergold, M; Gill-Schuster, D; Holzer, L | 1 |
| Hanke, K; Helm, M; Hossfeld, B; Kulla, M; Lechner, R; Mayer, B; Schmid, A | 1 |
1 review(s) available for dalteparin and phenprocoumon
| Article | Year |
|---|---|
[Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Electric Countershock; Enoxaparin; Heparin; Humans; International Normalized Ratio; Morpholines; Phenprocoumon; Practice Guidelines as Topic; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Warfarin | 2013 |
8 trial(s) available for dalteparin and phenprocoumon
| Article | Year |
|---|---|
Low molecular weight heparin for prevention of thromboembolic complications in cardioversion--rationale and design of the ACE study (Anticoagulation in Cardioversion using Enoxaparin).
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Transesophageal; Electric Countershock; Enoxaparin; Female; Heparin; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Phenprocoumon; Prospective Studies; Pulmonary Embolism; Risk Factors; Treatment Outcome; Venous Thrombosis | 2002 |
Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anticoagulants; Feasibility Studies; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Nadroparin; Outpatients; Phenprocoumon; Pulmonary Embolism; Risk; Treatment Outcome | 2003 |
Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Dalteparin; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Transesophageal; Electric Countershock; Female; Humans; Injections, Subcutaneous; Intracranial Embolism; Male; Middle Aged; Phenprocoumon; Premedication; Risk Factors; Thromboembolism; Treatment Outcome | 2003 |
Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE)
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Drug Therapy, Combination; Electric Countershock; Enoxaparin; Female; Hemorrhage; Heparin; Humans; Incidence; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Phenprocoumon; Safety; Thromboembolism; Treatment Outcome | 2004 |
The effect of oral anticoagulation on clotting during hemodialysis.
Topics: Administration, Oral; Aged; Anticoagulants; Blood Coagulation; Cross-Over Studies; Dalteparin; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Heparin, Low-Molecular-Weight; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phenprocoumon; Prospective Studies; Renal Dialysis; Thrombosis | 2005 |
Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (AC
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cohort Studies; Electric Countershock; Enoxaparin; Heparin; Humans; International Normalized Ratio; Partial Thromboplastin Time; Phenprocoumon; Prospective Studies; Thromboembolism; Time Factors | 2007 |
Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Echocardiography, Transesophageal; Electric Countershock; Enoxaparin; Female; Germany; Heparin; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Phenprocoumon; Prospective Studies; Thromboembolism; Treatment Outcome | 2007 |
How useful is determination of anti-factor Xa activity to guide bridging therapy with enoxaparin? A pilot study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Drug Administration Schedule; Drug Monitoring; Enoxaparin; Factor Xa Inhibitors; Hemorrhage; Humans; International Normalized Ratio; Linear Models; Logistic Models; Middle Aged; Partial Thromboplastin Time; Phenprocoumon; Pilot Projects; Predictive Value of Tests; Prospective Studies; Risk Assessment; Surgical Procedures, Operative; Thromboembolism; Treatment Outcome | 2009 |
16 other study(ies) available for dalteparin and phenprocoumon
| Article | Year |
|---|---|
[Heparin-induced thrombocytopenia type II].
Topics: Aged; Anticoagulants; Appendectomy; Female; Fibrinolytic Agents; Hirudin Therapy; Hirudins; Humans; Nadroparin; Perioperative Care; Phenprocoumon; Recombinant Proteins; Thrombocytopenia | 1999 |
Practicability and quality of outpatient management of acute deep venous thrombosis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anticoagulants; Bandages; Dalteparin; Female; Follow-Up Studies; Humans; Injections, Subcutaneous; Male; Middle Aged; Patient Compliance; Phenprocoumon; Phlebography; Retrospective Studies; Thrombophlebitis; Treatment Outcome; Ultrasonography, Doppler | 2000 |
[The first oral thrombin inhibitor. Competition to heparins and marcumar?].
Topics: Administration, Oral; Anticoagulants; Azetidines; Benzylamines; Clinical Trials as Topic; Enoxaparin; Fibrinolytic Agents; Glycine; Humans; Phenprocoumon; Placebos; Prodrugs; Thrombin; Thromboembolism; Thrombosis; Time Factors | 2003 |
Use of subcutaneous enoxaparin compared to intravenous heparin and oral phenprocoumon in the setting of cardioversion--the ACE study (Anticoagulation in Cardioversion using Enoxaparin).
Topics: Administration, Oral; Echocardiography, Transesophageal; Electric Countershock; Enoxaparin; Heparin; Humans; Infusions, Intravenous; Injections, Subcutaneous; Multicenter Studies as Topic; Phenprocoumon; Randomized Controlled Trials as Topic; Thromboembolism | 2003 |
[Marcumarized patient must have surgery. Playing it safe with low molecular weight heparin bridging].
Topics: Anticoagulants; Dose-Response Relationship, Drug; Drug Administration Schedule; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Phenprocoumon; Preoperative Care; Risk Factors; Thromboembolism | 2005 |
Once atrial fibrillation, always oral anticoagulation?
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Electric Countershock; Enoxaparin; Humans; International Normalized Ratio; Partial Thromboplastin Time; Phenprocoumon; Prospective Studies; Thromboembolism; Time Factors | 2007 |
[Abdominal tumor after persistent coughing and uncontrolled anticoagulation].
Topics: Abdomen, Acute; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Colonic Pseudo-Obstruction; Comorbidity; Cough; Dalteparin; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hematoma; Humans; Intracranial Embolism; Phenprocoumon; Rectus Abdominis; Ticlopidine | 2010 |
[Pulmonary embolism as a cause of a reduced performance capacity of endurance trained men - report of 2 cases].
Topics: Acute Disease; Angiography; Anticoagulants; Athletic Performance; Diagnosis, Differential; Electrocardiography; Enoxaparin; Exercise Test; Fibrin Fibrinogen Degradation Products; Follow-Up Studies; Humans; Male; Middle Aged; Oxygen; Phenprocoumon; Physical Endurance; Pulmonary Embolism; Running; Tomography, X-Ray Computed; Venous Thrombosis | 2010 |
Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation; Blood Loss, Surgical; Enoxaparin; Female; Germany; Hemorrhage; Humans; International Normalized Ratio; Male; Middle Aged; Phenprocoumon; Postoperative Hemorrhage; Prospective Studies; Registries; Risk Assessment; Risk Factors; Surgical Procedures, Operative; Thromboembolism; Time Factors | 2010 |
[Persistent left atrial thrombus in atrial fibrillation under oral anticoagulation].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Anticoagulants; Atrial Fibrillation; Drug Therapy, Combination; Echocardiography; Echocardiography, Transesophageal; Electric Countershock; Enoxaparin; Female; Heart Atria; Heart Diseases; Humans; International Normalized Ratio; Phenprocoumon; Risk Factors; Thromboembolism; Thrombosis; Tomography, X-Ray Computed | 2010 |
Coughing into the darkness.
Topics: Adult; Anticoagulants; Bronchitis; Carotid Artery, Internal; Constriction, Pathologic; Cough; Drug Administration Schedule; Headache; Humans; Intracranial Aneurysm; Intracranial Arteriovenous Malformations; Magnetic Resonance Imaging; Male; Music; Nadroparin; Phenprocoumon; Posterior Cerebral Artery | 2011 |
Cerebral venous sinus thrombosis at high altitude.
Topics: Altitude; Anticoagulants; Enoxaparin; Factor V; Female; Humans; Middle Aged; Phenprocoumon; Radiography; Sinus Thrombosis, Intracranial; Thrombophilia | 2012 |
Fatal basilar artery occlusion under dabigatran occurring 13 days after femoral embolectomy.
Topics: Aged; Anticoagulants; Antithrombins; Arterial Occlusive Diseases; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Angiography; Dabigatran; Drug Monitoring; Drug Therapy, Combination; Embolectomy; Embolism; Enoxaparin; Fatal Outcome; Femoral Artery; Humans; International Normalized Ratio; Male; Phenprocoumon; Vertebrobasilar Insufficiency | 2012 |
Obsessive-compulsive behavior as presenting symptom of primary antiphospholipid syndrome.
Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Caudate Nucleus; Diagnosis, Differential; Enoxaparin; Humans; Magnetic Resonance Imaging; Male; Obsessive-Compulsive Disorder; Phenprocoumon; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2013 |
Topics: Aged, 80 and over; Anesthesia, Spinal; Anticoagulants; Enoxaparin; Hemorrhage; Humans; Intraoperative Complications; Male; Phenprocoumon; Syndrome; Thrombosis; Transurethral Resection of Prostate; Urinary Bladder Diseases; Urologic Surgical Procedures | 2018 |
Hemostatics in patients with inhibited coagulation-A viscoelastic in-vitro analysis.
Topics: Anticoagulants; Aspirin; Enoxaparin; Hemostatics; Heparin; Humans; Phenprocoumon | 2023 |